Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice

Journal of Nutritional Biochemistry

Volumn 26, Issue 8, 2015, Pages 883-891

  Li, Wen ^a   Liu, Huan ^a   Yu, Min ^a   Zhang, Xumei ^a   Zhang, Meilin ^a   Wilson, John X ^b   Huang, Guowei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; DNA methylation; Folic acid; S adenosylmethionine

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DNA METHYLTRANSFERASE; FOLIC ACID; PRESENILIN 1; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; PRESENILIN 1, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DRUG MECHANISM; ENZYME ACTIVITY; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENE SILENCING; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; VITAMIN SUPPLEMENTATION; WEIGHT GAIN; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DISEASE MODEL; DNA SEQUENCE; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; HIPPOCAMPUS; METABOLISM; MOLECULAR GENETICS; PROMOTER REGION; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; FOLIC ACID; FOLIC ACID DEFICIENCY; GENE SILENCING; HIPPOCAMPUS; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PRESENILIN-1; PROMOTER REGIONS, GENETIC; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; SEQUENCE ANALYSIS, DNA;

EID: 84931573735     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.03.009     Document Type: Article

References (30)

1. De Strooper B., Iwatsubo T., Wolfe M.S. Presenilins and γ-secretase: structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med 2012, 2(1):a006304. 10.1101/cshperspect.a006304.
2. Christensen D.Z., Huettenrauch M., Mitkovski M., Pradier L., Wirths O. Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation. Front Aging Neurosci 2014, 6:139. 10.3389/fnagi.2014.00139. eCollection 2014.
3. Fuso A. The 'golden age' of DNA methylation in neurodegenerative diseases. Clin Chem Lab Med 2013, 51(3):523-534. 10.1515/cclm-2012-0618.
4. Bennett D.A., Yu L., Yang J., Srivastava G.P., Aubin C., De Jager P.L. Epigenomics of Alzheimer's disease. Transl Res 2014, 16. [pii: S1931-5244(14)00169-8]. 10.1016/j.trsl.2014.05.006.
5. Lunnon K., Mill J. Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies. Am J Med Genet B Neuropsychiatr Genet 2013, 162B(8):789-799. 10.1002/ajmg.b.32201.
6. Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS One 2008, 3(7):e2698. 10.1371/journal.pone.0002698.
7. Bakulski K.M., Dolinoy D.C., Sartor M.A., Paulson H.L., Konen J.R., Lieberman A.P., et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis 2012, 29(3):571-588. 10.3233/JAD-2012-111223.
8. Mandaviya P.R., Stolk L., Heil S.G. Homocysteine and DNA methylation: a review of animal and human literature. Mol Genet Metab 2014, 113(4):243-252. 10.1016/j.ymgme.2014.10.006.
9. Engelborghs S., Gilles C., Ivanoiu A., Vandewoude M. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease. Acta Clin Belg 2014, 69(1):17-24. 10.1179/0001551213Z.0000000006.
10. Jansen D., Zerbi V., Arnoldussen I.A., Wiesmann M., Rijpma A., Fang X.T., et al. Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice. PLoS One 2013, 8(9):e75393. [eCollection 2013]. 10.1371/journal.pone.0075393.
11. Moore E.M., Ames D., Mander A.G., Carne R.P., Brodaty H., Woodward M.C., et al. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. J Alzheimers Dis 2014, 39(3):661-668. 10.3233/JAD-131265.
12. Thaipisuttikul P., Galvin J.E. Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease. Clin Pract (Lond) 2012, 9(2):199-209.
13. Clarke R., Bennett D., Parish S., Lewington S., Skeaff M., Eussen S.J., et al. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. Am J Clin Nutr 2014, 100(2):657-666.
14. Durga J., van Boxtel M.P., Schouten E.G., Kok F.J., Jolles J., Katan M.B., et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007, 369(9557):208-216.
15. Chan A., Paskavitz J., Remington R., Rasmussen S., Shea T.B. Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension. Am J Alzheimers Dis Other Demen 2008, 23(6):571-585. 10.1177/1533317508325093.
16. Strain J.J., Dowey L., Ward M., Pentieva K., McNulty H. B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc 2004, 63(4):597-603.
17. Song Z., Zhou Z., Song M., Uriarte S., Chen T., Deaciuc I., et al. Alcohol-induced S-adenosylhomocysteine accumulation in the liver sensitizes to TNF hepatotoxicity: possible involvement of mitochondrial S-adenosylmethionine transport. Biochem Pharmacol 2007, 74(3):521-531.
18. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging 2011, 32(7):1161-1180. 10.1016/j.neurobiolaging.2010.08.017.
19. Fuso A., Nicolia V., Ricceri L., Cavallaro R.A., Isopi E., Mangia F., et al. S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging 2012, 33(7):1482.e1-1482.e16. 10.1016/j.neurobiolaging.2011.12.013.
20. Lee S., Lemere C.A., Frost J.L., Shea T.B. Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice. J Alzheimers Dis 2012, 28(2):423-431. 10.3233/JAD-2011-111025.
21. Webster S.J., Bachstetter A.D., Nelson P.T., Schmitt F.A., Van Eldik L.J. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 2014, 5:88. 10.3389/fgene.2014.00088. eCollection 2014.
22. Salloway S., Sperling R., Fox N.C., Blennow K., Klunk W., Raskind M., et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med 2014, 370(4):322-333. 10.1056/NEJMoa1304839.
23. Faux N.G., Ellis K.A., Porter L., Fowler C.J., Laws S.M., Martins R.N., et al. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. J Alzheimers Dis 2011, 27(4):909-922. 10.3233/JAD-2011-110752.
24. Kennedy B.P., Bottiglieri T., Arning E., Ziegler M.G., Hansen L.A., Masliah E. Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J Neural Transm 2004, 111(4):547-567.
25. Chouliaras L., Mastroeni D., Delvaux E., Grover A., Kenis G., Hof P.R., et al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol Aging 2013, 34(9):2091-2099. 10.1016/j.neurobiolaging.2013.02.021.
26. Sudduth T.L., Weekman E.M., Brothers H.M., Braun K., Wilcock D.M. β-Amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice. Alzheimers Res Ther 2014, 6(3):32. 10.1186/alzrt262. eCollection 2014.
27. Lin N., Qin S., Luo S., Cui S., Huang G., Zhang X. Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation in vitro. FEBS J 2014, 281(8):2088-2096. 10.1111/febs.12764.
28. Li W., Yu M., Luo S., Liu H., Gao Y., Wilson J.X., et al. DNA methyltransferase mediates dose-dependent stimulation of neural stem cell proliferation by folate. J Nutr Biochem 2013, 24(7):1295-1301. 10.1016/j.jnutbio.2012.11.001.
29. Yu M., Li W., Luo S., Zhang Y., Liu H., Gao Y., et al. Folic acid stimulation of neural stem cell proliferation is associated with altered methylation profile of PI3K/Akt/CREB. J Nutr Biochem 2014, 25(4):496-502. 10.1016/j.jnutbio.2013.12.010.
30. Do T.M., Alata W., Dodacki A., Traversy M.T., Chacun H., Pradier L., et al. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease. Neuropharmacology 2014, 81:311-317. 10.1016/j.neuropharm.2014.02.010.